Leading the Charge for the Morning-After Pill
by Loolwa Khazzoom • February 7, 2010 • Health & Wellness , The Boston Globe
Though the Food and Drug Administration’s official rejection stated that the morning-after pill had not been tested on enough girls under 16, reproductive-rights organizations and activists — including Annie Tummino of Middleborough, MA — assert that the real reason the FDA rejected over-the-counter status was pressure from the Bush administration. This article provides an investigative report on Tummino’s lawsuit against the FDA.
Loolwa Khazzoom has published two books and has published numerous articles for leading periodicals. Her current focus is on health & wellness writing, with a speciality in complementary and alternative medicine in general and natural pain relief in particular.
